Histiocytic sarcoma progressing from follicular lymphoma and mimicking acquired hemophagocytic lymphohistiocytosis

Ann Hematol. 2020 Oct;99(10):2441-2443. doi: 10.1007/s00277-020-04190-4. Epub 2020 Aug 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antigens, CD / analysis
  • Antigens, Neoplasm / analysis
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor
  • Bone Marrow / pathology
  • Chromosomes, Human, Pair 14 / genetics
  • Chromosomes, Human, Pair 14 / ultrastructure
  • Chromosomes, Human, Pair 18 / genetics
  • Chromosomes, Human, Pair 18 / ultrastructure
  • Cyclophosphamide / administration & dosage
  • Dexamethasone / administration & dosage
  • Diagnosis, Differential
  • Disease Progression
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Histiocytic Sarcoma / diagnosis
  • Histiocytic Sarcoma / drug therapy
  • Histiocytic Sarcoma / genetics
  • Histiocytic Sarcoma / pathology*
  • Humans
  • Lymph Nodes / pathology
  • Lymphohistiocytosis, Hemophagocytic / diagnosis*
  • Lymphoma, Follicular / drug therapy
  • Lymphoma, Follicular / genetics
  • Lymphoma, Follicular / pathology*
  • Middle Aged
  • Prednisolone / administration & dosage
  • Rituximab / administration & dosage
  • Translocation, Genetic
  • Vincristine / administration & dosage

Substances

  • Antigens, CD
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Rituximab
  • Vincristine
  • Etoposide
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone

Supplementary concepts

  • CHOEP protocol